Close Menu

Cancer Genetics

Genetic Technologies will distribute the ResponseDX tests in Australia and in five SE Asian Nations.

Sales for the firm's ResponseDx pharmacogenomic tests more than doubled from the second quarter of 2009.

The firm said sales of its ResponseDx tests rose 70 percent from the first quarter.

The private placement follows a restructuring undertaken earlier this year by the molecular diagnostics firm.

GSK and Abbott will develop a companion diagnostic for GSK's investigational MAGE-A3 immunotherapy. After discussions with the FDA, GSK believes the drug and diagnostic will be reviewed simultaneously, and labeling language for the drug will require genetic testing prior to treatment.

Snippets: Apr 1, 2009


Epigenomics, Response Genetics, Exact Sciences

The firm's Q4 revenues dropped 41 percent, but it noted that test sales are up in the first quarter.

The company said that shuttering the UK facility will save it around $2.3 million in annual expenses.

Snippets: Feb 4, 2009


National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Roche will use Response Genetics' technology to assess a HER2 expression test.


Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.